Glioblastoma
Showing NaN - NaN of 75
The PALSUR-study: Palliative Care Versus Surgery in High-grade
Recruiting
- Glioblastoma
- +3 more
- Palliative Care
- +2 more
-
San Francisco, California
- +7 more
Nov 18, 2023
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma
Recruiting
- Glioblastoma
- +4 more
- Tumor resection
- Tumor biopsy
-
San Francisco, California
- +7 more
Nov 18, 2023
Supramaximal Resection Versus Maximal Resection for High-Grade
Recruiting
- Glioblastoma
- +11 more
- Supramaximal resection
- Maximal safe resection
-
San Francisco, California
- +7 more
Nov 1, 2023
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 2, 2023
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)
Recruiting
- Diffuse Astrocytoma
- +22 more
-
Phoenix, Arizona
- +26 more
Jan 27, 2023
Glioblastoma Trial in Boston (ITI-1001)
Not yet recruiting
- Glioblastoma
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 13, 2023
Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,
Recruiting
- Glioblastoma
- +3 more
- Nivolumab-Placebo
- +4 more
-
Los Angeles, California
- +3 more
Jan 16, 2023
Glioblastoma, Recurrent Glioblastoma Trial in United States (ASP8374, cemiplimab)
Active, not recruiting
- Glioblastoma
- Recurrent Glioblastoma
-
Boston, Massachusetts
- +3 more
Jan 13, 2023
Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)
Active, not recruiting
- Anaplastic Astrocytoma
- +2 more
- Radiation Therapy
- +2 more
-
Birmingham, Alabama
- +162 more
Dec 30, 2022
Glioblastoma Trial in United States (Abemaciclib, Surgery)
Active, not recruiting
- Glioblastoma
- Abemaciclib
- Surgery
-
Los Angeles, California
- +6 more
Dec 28, 2022
Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Boston (CARv3-TEAM-E T cells)
Not yet recruiting
- Glioblastoma
- +3 more
- CARv3-TEAM-E T cells
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Dec 13, 2022
Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,
Recruiting
- Advanced Solid Tumors
- +11 more
-
Boston, Massachusetts
- +4 more
Dec 12, 2022
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)
Active, not recruiting
- Glioblastoma
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 16, 2022
Molecular Genetic, Host-derived and Clinical Determinants of
Active, not recruiting
- Glioblastoma
- Blood drawl
-
Boston, Massachusetts
- +26 more
Sep 13, 2022
Glioma, Glioblastoma Trial in United States (Focused ultrasound (FUS))
Active, not recruiting
- Glioma
- Glioblastoma
- Focused ultrasound (FUS)
-
Baltimore, Maryland
- +3 more
Sep 8, 2022
Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)
Recruiting
- Advanced Malignant Solid Neoplasm
- +6 more
-
Costa Mesa, California
- +49 more
Aug 24, 2022
Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)
Recruiting
- Glioblastoma
- +5 more
- Ipilimumab
- +4 more
-
Birmingham, Alabama
- +19 more
Aug 16, 2022
Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus
Recruiting
- Mesothelioma
- +14 more
- NGM707
- NGM707 plus pembrolizumab
-
Los Angeles, California
- +13 more
Aug 16, 2022